INFUSYSTEM HOLDINGS, INC Employee Stock Ownership Plan (ESOP), Compensation Expense
INFUSYSTEM HOLDINGS, INC (INFU) reported Employee Stock Ownership Plan (ESOP), Compensation Expense of $139.14 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EmployeeStockOwnershipPlanESOPCompensationExpense · last filed 2026-02-27
- INFUSYSTEM HOLDINGS, INC employee stock ownership plan (esop), compensation expense for fiscal 2025 was $139.14K, a 48.78% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC employee stock ownership plan (esop), compensation expense for fiscal 2024 was $93.52K, a 47.93% decline from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC employee stock ownership plan (esop), compensation expense for fiscal 2023 was $179.59K, a 21.60% decline from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC employee stock ownership plan (esop), compensation expense for fiscal 2022 was $229.06K, a 31.98% increase from fiscal 2021.
| Period end | Employee Stock Ownership Plan (ESOP), Compensation Expense 12 month |
|---|---|
| 2025-12-31 | $139.14K 10-K · filed 2026-02-27 |
| 2024-12-31 | $93.52K 10-K · filed 2026-02-27 |
| 2023-12-31 | $179.59K 10-K · filed 2025-03-11 |
| 2022-12-31 | $229.06K 10-K · filed 2024-04-10 |
| 2021-12-31 | $173.56K 10-K · filed 2024-04-10 |
| 2020-12-31 | $108.59K 10-K · filed 2023-03-16 |
| 2019-12-31 | $43.03K 10-K · filed 2022-03-15 |
| 2018-12-31 | $33.87K 10-K · filed 2020-03-30 |
| 2017-12-31 | $49.15K 10-K · filed 2019-03-22 |
| 2016-12-31 | $113.53K 10-K · filed 2018-03-19 |
| 2015-12-31 | $40.23K 10-K · filed 2017-03-22 |
| 2014-12-31 | $0.00 10-K/A · filed 2016-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |